Clene (CLNNW) had the highest return in 2022 and on October 31, 2022 by a small-cap US stock, returning 53.6%.
| ASSET | % RETURN |
|---|---|
Clene (CLNNW) | 53.6% |
Getty Images (GETY) | 34.65% |
Spyre Therapeutics (SYRE) | 22.33% |
Cimpress (CMPR) | 14.51% |
Power Solutions International, Inc Common Stock (PSIX) | 14.29% |
RPC (RES) | 13.8% |
Tilray (TLRY) | 13.06% |
NRx Pharmaceuticals (NRXPW) | 12.5% |
Zymeworks Inc Common Stock (ZYME) | 11.06% |
Opera (OPRA) | 10.93% |
Uxin (UXIN) | 10.75% |
Braskem SA Class A (BAK) | 10.61% |
Castle Biosciences (CSTL) | 9.86% |
Advent Technologies (ADNWW) | 9.68% |
Borr Drilling (BORR) | 9.6% |
Arko (ARKOW) | 9.22% |
Eos Energy Enterprises (EOSE) | 9.15% |
LifeMD (LFMD) | 8.96% |
SNDL (SNDL) | 8.85% |
Selectquote (SLQT) | 8.71% |
Hippo (HIPO) | 8.41% |
TheRealReal (REAL) | 8.33% |
Global Partners (GLP) | 8.25% |
TSS, Inc Common Stock (TSSI) | 8.07% |
Helix Energy Solutions (HLX) | 8.02% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
